https://www.avient.com/news/avient-unveils-high-temperature-vibrant-colorants-healthcare-mdm-west-2022
March 30, 2022
CLEVELAND – March 30, 2022 – Avient today announced that it will launch new biocompatible colorants at the upcoming Medical Device & Manufacturing West exhibition in Anaheim, California.
https://www.avient.com/news/polyone-color-inspirations-2020-brings-visionary-concepts-focus
March 18, 2019
CLEVELAND – March 18, 2019 – In a perfect world, all could see clearly into the future.
https://www.avient.com/news/avient-featuring-colorants-and-additives-recycling-challenges-2023-plastics-recycling-conference
During the conference, Sean Bernhardt, senior manager, Technology, will take the Innovation Stage on Tuesday, March 7 at 5:30 PM to discuss recycling challenges and share an overview of the CycleWorks™ innovation center – Avient’s testing facility that explores real-world recycling in a research environment.
Avient will exhibit at booth #710 in the Gaylord National Resort & Convention Center in Maryland, March 6-8, 2023.
https://www.avient.com/sites/default/files/2022-04/Sustainable Material Answers_ Recycled PET 2022.pdf
What is rPET?
What’s Up Next for rPET?
What’s Up Next for rPET?
https://www.avient.com/sites/default/files/2022-11/Packaging Anti-fog Whitepaper.pdf
WHAT IS FOGGING AND HOW CAN WE PREVENT IT?
What is fog?
In addition, laboratory tests indicate that these additives produce anti- fog properties at a slightly faster rate than other additive solutions.
https://www.avient.com/news/archives?page=12
January 22, 2024
January 22, 2024
January 19, 2024
https://www.avient.com/stock-quote
2024 Annual Report
Read about our 2024 performance.
https://www.avient.com/company/sustainability/sustainability-report/reporting/cdp-climate-change-report
CDP Corporate Questionnaire 2024
Third Party Verification of Climate Change Score Report 2024
https://www.avient.com/investor-center/events/q4-avient-corporation-earnings-conference-call-0
Oct 31, 2024
Aug 06, 2024
May 07, 2024
https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
When showing constant dollar figures on GAAP and non-GAAP financial measures, the foreign exchange impact is calculated by using current foreign exchange rates and applying them to the prior period results.
For the same reasons, Avient is unable to address the probable significance of the unavailable information. 2 3 AVIENT OVERVIEW 2023 Financial ResultsCompany Overview Revenue By: 9,300 Employees 102 Manufacturing Sites 20,000+ Customers Innovating materials and processing solutions to solve our customers’ challenges while enabling a sustainable world Broad portfolio of technologies with market leading positions and flexibility to anticipate and meet customer needs Focus is on organic revenue growth and margin expansion, following our successful portfolio transformation $3.14B Revenue $2.36 Adjusted EPS $502M Adjusted EBITDA 16.0% Adjusted EBITDA Margins $186M Adjusted Free Cash Flow U.S. & Canada EMEA Asia Latin America 64% 36% Specialty Engineered Materials Color Additives and Inks 41% 36% 18% 5% 7% 7% 23% 19% 9% 16% 10% 5% 4% Defense Healthcare Packaging Consumer Building & Construction Industrial Transportation Energy Telecom Geography Segment Industry 2024 Financial Guidance $525 to $530 million Adjusted EBITDA $2.63 to $2.67 Adjusted EPS 4 Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile Avient CDP Score: A- SUSTAINABILITY PERFORMANCE AND RECOGNITION O CTO BE R 3 1 , 2024 W EB CAS T P RE SE N TATI O N 6 Q3 2024 HIGHLIGHTS • 8.5% organic sales growth driven by broad-based growth across all regions and most end markets in both CAI and SEM segments • Growth stemmed from gaining share, winning new product specifications and restocking in certain end markets • Both segments expanded YoY EBITDA margins by 40 bps each • Adjusted EPS of $0.65, an increase of 14% vs the prior year • Successfully refinanced $650M outstanding senior notes due 2025; extending maturity to 2031 • Increased dividend 5% to $1.08 on an annualized basis; 14th consecutive increase Adj.
EBITDA $130 million +6% (+7% ex FX)Net Sales $815 million +8% (+8.5% ex FX) Net Sales $815 million +8% (+8.5% ex FX) Q 3 2024 R ES U LT S TOTAL COMPANY (Q3 2024 PERFORMANCE VS Q3 2023) $754 $815 Q3 23 Q3 24 $123 $130 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) $0.57 $0.65 Q3 23 Q3 24 (in millions) Adjusted EBITDA Adjusted EPS 8 + 8% (+8.5% excluding FX) + 6% (+7% excluding FX) + 14% (+16% excluding FX) Sales 9 Q3 2024 RESULTS – ORGANIC REVENUE GROWTH BY REGION VS PY 9 US & Canada Latin America EMEA Asia +9% +5% +11% +27% Avient ex.